[A patient with systemic scleroderma showing improvement during long-term hemodialysis after renal crisis].
A 68-year-old man experienced systemic pruritus since he was 63 years old, and systemic sclerosis and skin pigmentation were observed when he was 64. When he developed dyspnea the same year, he was admitted and SSc was diagnosed on the basis of the clinical and skin biopsy findings, lung fibrosis on X-P and TBLB findings. At 65, his dyspnea reappeared along with elevated blood pressure, acute renal failure and lung congestion, and he was diagnosed as having a scleroderma renal crisis (SRC) from the clinical and renal biopsy findings. Hemodialysis was started because he showed mental disturbance, and this and other acute symptoms were subsequently reduced. As he showed no recovery from his renal failure, the patient has been maintained on hemodialysis for over four years now. In the meantime, his sclerosis has improved and antinuclear antibody almost disappeared. Hemodialysis appears to be the most likely reason for his improvement, although spontaneous remission, D-penicillamine and angiotensin converting enzyme (ACE) inhibitor therapy may also have contributed, considering the short period and the small amount of drugs given until improvement.
Fuse
Y
Y
Tohkai Clinic, Tokai-city.
Muramatsu
M
M
Sugiyama
S
S
Maeda
K
K
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology / Q000628:therapy*; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D006435:Renal Dialysis; D012595:Scleroderma, Systemic / Q000150:complications / Q000628:therapy*; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D018501:Antirheumatic Agents; D010396:Penicillamine